BAM
LEGN icon

Blueshift Asset Management’s Legend Biotech LEGN Stock Holding History

Blueshift Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,871
Closed -$446K – 1157
2021
Q2 		$446K Buy
+10,871
New +$369K 0.02% 599

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Blueshift Asset Management's LEGN Position: Q3 2021 in Review

Blueshift Asset Management sold out of Legend Biotech (LEGN) in Q3 2021, closing a stake of 10,871 shares — an estimated $446K sold.

Blueshift Asset Management first reported a position in LEGN in Q2 2021 and held it in 1 quarter. The position peaked at $446K in Q2 2021. 88 funds tracked by Wall St. Rank hold LEGN as of Q3 2021.

  • Blueshift Asset Management reported no remaining Legend Biotech position as of Q3 2021 after selling out during the quarter.
  • Blueshift Asset Management sold 10,871 Legend Biotech shares in Q3 2021, an estimated $446K.
  • Blueshift Asset Management first reported a position in Legend Biotech in Q2 2021 and held it in 1 quarter.
  • Blueshift Asset Management's Legend Biotech position peaked at $446K in Q2 2021.
  • 88 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2021.

Based on Blueshift Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.